Pacific Biosciences Of California (PACB) EBITDA Margin (QoQ) (2010 - 2026)
Pacific Biosciences Of California (PACB) EBITDA Margin (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn |
| 10 | Pacific Biosciences Of California | 381.79 Mn | 144.92 Mn | 12.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -9,189.00 |
| Mar 31, 2026 | 6,980.00 |
| Dec 31, 2025 | 886.00 |
| Sep 30, 2025 | 1,166.00 |
| Jun 30, 2025 | 104,171.00 |
| Mar 31, 2025 | -76,437.00 |
| Dec 31, 2024 | -22,981.00 |
| Sep 30, 2024 | 32,796.00 |
| Jun 30, 2024 | -27,864.00 |
| Mar 31, 2024 | -5,962.00 |
| Dec 31, 2023 | -190.00 |
| Sep 30, 2023 | 569.00 |
| Jun 30, 2023 | 8,076.00 |
| Mar 31, 2023 | 8,379.00 |
| Dec 31, 2022 | -8,743.00 |
| Sep 30, 2022 | -3,930.00 |
| Jun 30, 2022 | 4,205.00 |
| Mar 31, 2022 | -5,413.00 |
| Jun 30, 2021 | -649.00 |
| Mar 31, 2021 | -2,789.00 |